Decompensated Heart Failure
37
8
9
11
Key Insights
Highlights
Success Rate
79% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
8.1%
3 terminated out of 37 trials
78.6%
-7.9% vs benchmark
5%
2 trials in Phase 3/4
18%
2 of 11 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 11 completed trials
Clinical Trials (37)
Cardiac Rehabilitation in Decompensated Heart Failure
Characterisation of phenotYpes in aCute Heart faiLure patiEnts
Vericiguat in Decompensated Cardiac Failure: Clinical Insights on Addition to Guidelines Derived Medical Therapy-VERCIG Trial
Optimizing Treatments for Heart Failure During Hospitalization
Hospital Register of Decompensated Heart Failure With Preserved Ejection Fraction
Use of Point-of-Care Ultrasound (POCUS) to Reduce Hospital Length of Stay in Patients With Heart Failure ( POCUSHF )
Mechanism and Effects of Manipulating Chloride Homeostasis in Stable Heart Failure
Bioimpedance Integration for Optimized Fluid Management in Decompensated Heart Failure
BIO|CONCEPT.BIOMONITOR-HF Collect Clinical Data From Heart Failure Patients Using BIOMONITOR Devices With a Study Specific Research Software
A Prospective, Observational, Single Centre Study to Assess the Feasibility of the Data Harvested by the Acorai Intracardiac Pressure Monitoring (ICPM) System in Predicting Prognosis in Patients Discharged From Hospital After Treatment for Acute Decompensated Heart Failure
Colchicine in Acutely Decompensated HFREF
Monocyte Phenotypic Changes in Heart Failure
Acetazolamide or Metolazone in Acute Heart Failure
Strategies for Assessment of Fluid Overload in Acute Decompensated Heart Failure
Effect on Kidney Function Recovery Guiding Decongestion With VExUS in Patients With Cardiorenal Syndrome 1
Shear Wave Elastography
Sensation of Dyspnea and Experience of Patients With Heart Failure
Assessment of ProEnkephalin to Detect Acute Kidney Injury (AKI)
Metabolic Alkalosis in Heart Failure
Innovative Technologies for the Treatment of Pulmonary and Heart Failure